Aslan acquires global rights to cancer treatment

04-01-2018

Aslan acquires global rights to cancer treatment

CIPhotos / iStockphoto.com

Singapore-based Aslan Pharmaceuticals has acquired the full global rights to develop, manufacture and commercialise a cancer treatment.


Aslan Pharmaceuticals, cancer, biotech, research, licensing, treatments, immunotherapy, patents, Array BioPharma

LSIPR